Folate with methotrexate: Big benefit, questionable cost [17]

British Journal of Dermatology

Volumn 157, Issue 1, 2007, Pages 213-

  Brownell, I ^a   Strober, B E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; FOLINIC ACID; METHOTREXATE; PLACEBO;

CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PSORIASIS; RECOMMENDED DRUG DOSE; STATISTICAL SIGNIFICANCE;

COSTS AND COST ANALYSIS; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; FOLIC ACID; HUMANS; METHOTREXATE; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 34250673494     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08005.x     Document Type: Letter

References (3)

1. Salim A, Tan E, Ilchyshyn A, Berth-Jones J. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 2006 154 : 1169 74.
2. Strober BE, Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 2005 53 : 652 9.
3. Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 2004 43 : 267 71.